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Background: The ratio between amygdala:hippocampal (AH) volume has been associated with multiple psychiatric
problems, including anxiety and aggression. Yet, little is known about its biological underpinnings. Here, we used a
methylome-wide approach to test (a) whether DNAmethylation in early life (birth, age 7) prospectively associates with
total AH volume ratio in early adulthood, and (b) whether significant DNA methylation markers are influenced by
prenatal risk factors. Methods: Analyses were based on a subsample (n = 109 males) from the Avon Longitudinal
Study of Parents and Children, which included measures of prenatal risk, DNAmethylation (Infinium Illumina 450k),
T1-weighted brain scans and psychopathology in early adulthood (age 18–21). Amygdala and hippocampus
measures were derived using Freesurfer 5.3.0. Methylation markers related to AH volume ratio across time were
identified using longitudinal multilevel modeling. Results: Amygdala:hippocampal volume ratio correlated positively
with age 18 psychosis-like symptoms (p = .007). Methylation of a probe in the gene SP6 associated longitudinally
with (a) higher AH volume ratio (FDR q-value = .01) and (b) higher stressful life events during pregnancy (p = .046).
SP6 is expressed in the hippocampus and amygdala and has been implicated in cognitive decline in Alzheimer’s
disease. The association between SP6 DNA methylation, AH volume ratio and psychopathology was replicated in an
independent dataset of 101 patients with schizophrenia and 111 healthy controls. Conclusions: Our findings
suggest that epigenetic alterations in genes implicated in neurodevelopment may contribute to a brain-based
biomarker of psychopathology. Keywords: DNA methylation; methylome-wide; amygdala; hippocampus;
longitudinal; Avon Longitudinal Study of Parents and Children.
Introduction
Structural alterations in amygdala and hippocam-
pus volume have been linked to a range of psychi-
atric problems, including anxiety, depression, and
aggressive behavior (Campbell, Marriott, Nahmias, &
MacQueen, 2004; Pardini, Raine, Erickson, & Loe-
ber, 2014; Schmaal et al., 2016). However, the effect
sizes reported so far have been small (Cohen’s
d < 0.2) and findings mixed with regard to the
directionality and stability of effects. For example,
when comparing patients with depression versus
controls, some studies have reported a volume
increase (Visser et al., 2014), others a decrease
(Matthies et al., 2012; Thijssen et al., 2015) and
others still only acute-disease state associations
(Ahdidan et al., 2011; Arnone et al., 2013).
Considering that these structures are both part of
the limbic system and are structurally and function-
ally connected, examining these subcortical struc-
tures in the context of one another may be more
informative than studying each region in isolation.
For instance, a study by Gerritsen et al. (2012) found
that a larger amygdala:hippocampal (AH) volume
ratio associated with more severe biases toward
negative memories (an important cognitive marker
of depression) in nondepressed controls, while only
weak associations were found when assessing each
structure separately. Specifically, compared with
persons without negative memory bias, persons with
negative memory bias had a 6.3% higher AH volume
ratio, but only a 2.2% larger amygdala volume and
3.7% smaller hippocampal volume. Similarly, an
increased AH volume ratio (rather than structure-
specific effects) was found to be correlated strongly
(r = .62) with severity of anxiety in medication-naive
first-episode patients with depression (MacMillan
et al., 2003). Both studies point toward medication-
independent effects, which seem to predate illness
onset and might hence be a marker of disease
vulnerability. In line with this, a study by Gilliam
et al. (2014) reported a weak association (r = .19)
between AH volume ratio and aggressive behavior
(but not depression) in a community sample of young
men. The study also found that AH volume ratio
mediated the association between maternal depres-
sion and later aggression, pointing to a potentially
important role of the early environment in AH
volume ratio and associated psychopathological
outcomes.
Despite these promising findings, little is currently
known about the biological underpinnings of an AHConflict of interest statement: No conflicts declared.
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volume ratio, as previous models of psychopathology
have primarily focused on the biological mechanisms
involved in hippocampal atrophy. For instance, the
‘neurotrophic hypothesis of depression’ postulates
that chronic hyperactivity of the hypothalamic–pitu-
itary–adrenal axis – often due to environmental
stress exposure – leads to increased glucocorticoid
levels that can downregulate the activity of growth
factors such as BDNF, which over time can result in
brain atrophy (Campbell & MacQueen, 2004). Con-
sidering that glucocorticoid receptor expression is
high in the hippocampus (Sapolsky, Krey, & McE-
wen, 1984), this region might be particularly dam-
aged. However, evidence suggests that the amygdala
may also be affected. For example, Govindarajan
et al. (2006) studied transgenic mice, which overex-
pressed BDNF, and observed (a) increased anxiety-
like behavior and spinogenesis of the amygdala and
(b) decreased depressive symptoms and hippocam-
pal atrophy. In line with these antagonistic findings,
Manna et al. (2015) reported BDNF levels in healthy
elderly individuals to be correlated positively with
mean diffusivity in the amygdala, but negatively with
that in the hippocampus. These findings suggest
that across certain imaging modalities hippocampal
deficiency in depression might be inversely linked to
amygdala deficits (i.e., a larger AH volume ratio).
That is, both structures form an interconnected
network, which jointly responds to changes in bio-
logical signals.
The mechanisms underlying environmental, stress-
related effects on an AH volume ratio remain unclear.
Epigenetic processes, such as DNA methylation,
have recently emerged as a candidate mechanism
for biological embedding. Epigenetic profiles of the
hippocampus and the amygdala have been examined
in healthy controls and in relation to a range of
psychiatric disorders such as schizophrenia and
depression. Taking a gene set enrichment approach
using methylome-wide data, Hass et al. (2015) found
altered epigenetic patterns in the hsa-miR-219a-5p
microRNA target gene set to correlate with hip-
pocampal volume in a schizophrenia sample. Methy-
lation in the serotonin transporter gene SLC6A4, a
risk locus for depression, has been found to associ-
ate with hippocampal grey matter volume and parts
of the amygdala in healthy controls (Dannlowski
et al., 2014). Similar effects have been observed in
patients with depression (Booij et al., 2015), where
methylation also related to childhood abuse. With
respect to prenatal risk factors, several longitudinal
studies have found that exposures such as parental
social risks, maternal adiposity, and smoking during
pregnancy influence offspring DNA methylation
(Cecil et al., 2014; Richmond et al., 2015; Sharp
et al., 2015). However, to our knowledge no study so
far has examined the prospective epigenetic corre-
lates of an AH volume ratio and how these may
connect to the early-life environment. Moreover,
given that DNA methylation is dynamic across the
life span, findings of any cross-sectional study might
only apply to the time period under investigation
(Martino et al., 2013). It is, therefore, not surprising
that in the few existing longitudinal epigenetic stud-
ies, most markers identified were not found to
consistently associate with prenatal exposures
across time points (Cecil et al., 2014; Richmond
et al., 2015; Rijlaarsdam et al., 2017; Sharp et al.,
2015). Considering that subcortical brain mat-
uration is a continuous process during development
(Østby et al., 2009), we were interested in DNA
methylation markers that are robustly and
longitudinally associated with AH volume ratio.
Consequently, in this study we employed a methy-
lome-wide approach to test (a) whether DNA methy-
lation in childhood (birth and age 7) prospectively
associates with total AH volume ratio in early adult-
hood, and (b) whether significant DNA methylation
markers are influenced by prenatal risk factors.
Methods
Participants
Participants were drawn from the Accessible Resource for
Integrated Epigenomics Studies (ARIES, www.ariesepigenomics.
org.uk, Relton et al., 2015), a study nested within the Avon
Longitudinal Study of Parents and Children (ALSPAC) that
contains DNA methylation data for a subset of 1,018 mother–
offspring pairs. ALSPAC is an ongoing epidemiological study of
children born from 14,541 pregnant women residing in Avon,
UK, with an expected delivery date between April 1991 and
December 1992 (85% of eligible population; Fraser et al.,
2013). Ethical approval for the study was obtained from the
ALSPAC Ethics and Law Committee and the Local Research
Ethics Committees. The original sample is representative of the
general population (Boyd et al., 2013). Please note that the
study website contains details of all the data that is available
through a fully searchable data dictionary: http://www.b
ris.ac.uk/alspac/researchers/data-access/data-dictionary/.
Subsample with brain magnetic resonance imag-
ing. A total of 507 male participants underwent brain MR
imaging between the age of 18–21 years (Mean  SD:
235.5 months  10.1 months, range: 216–258 months). Only
male participants were scanned owing to the focus of the NIH
grant funding this work (R01MH085772-01A1; Axon, Testos-
terone and Mental Health during Adolescence). Participants
were selected based on their current domicile being within a 3-
hr journey (one-way) from the scanning site. We excluded 14
participants due to a failure to pass quality control of
FreeSurfer-based image-analysis pipeline (see below). For this
study, we included only youth from ARIES who had available
data on brain measures (age 18–21) as well as epigenetic data
at birth and at age 7. The final dataset consisted of 109
participants (all males).
Measures
DNA methylation data. Five hundred nanograms of
genomic DNA from blood (cord at birth; whole at age 7; ARIES
sample) was bisulfite-converted using the EZ-DNA methylation
kit (Zymo Research, Orange, CA). DNAm was quantified using
the Illumina HumanMethylation450 BeadChip (Illumina, San
Diego, CA) with arrays scanned using an Illumina iScan
© 2017 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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(software version 3.3.28). Initial data quality control was
conducted using GenomeStudio (version 2011.1, Illumina) to
determine the status of staining, extension, hybridization,
target removal, bisulfite conversion, specificity, nonpolymor-
phic, and negative controls. Samples and probes that survived
initial data quality control using GenomeStudio (version
2011.1, Illumina) and background detection p-value <.05 were
quantile normalized using the dasen function within the
wateRmelon package (wateRmelon_1.0.3; Pidsley et al., 2013)
in R and indexed by beta values (ratio of methylated signal
divided by the sum of the methylated and unmethylated
signal). Probes were removed if they were cross-reactive,
polymorphic, used for sample identification on the array or
had a SNP at the single base extension (n = 72,068). We also
removed participants with non-Caucasian or missing ethnicity
(based on self-reports; n = 61). As a final step, we regressed out
chip and cell type as detailed in Houseman et al. (2012) to
remove potentially confounding effects. The resulting dataset
consisted of a total of 407,462 probes and 828 samples (cord)
and 410,075 probes and 903 samples (age 7), before pruning for
brain measures (see below). For more information, see section
1.1 in Supporting information.
Brain MRI acquisition and preprocessing. Brain MR
images were acquired on a 3T magnet (GE, Chicago, IL) using
an 8-channel receiver-only head coil (GE). T1-weighted images
were obtained using a 3D fast spoiled gradient-echo sequence
using the following parameters: oblique-axial orientation
(plane passing through the anterior–posterior commissures),
1-mm isotropic, field of view 256 9 192 9 210 mm,
TR = 7.9 ms, TE = 3.0 ms, TI = 450 ms and Flip angle = 20°.
Segmentation and surface reconstruction quality were assured
by manual inspection of all raw brain MRI volumes, segmented
volumes in three planes and pial as well as inflated volumes.
Fourteen participants’ brain MRI data failed this quality
assurance and were removed from the analysis. Hippocampal,
amygdala and intracranial volume measures are a standard
output of the FreeSurfer 5.3.0 volumetric segmentation (Fischl
et al., 2002). For this study, we derived a measure of total AH
volume ratio by dividing total (i.e., left and right) amygdala
volume by total hippocampus volume.
Prenatal environmental risk. Prenatal environmental
risk scores were available for 102 participants and created
based on maternal reports on four conceptually distinct but
related risk domains: (a) Life events (e.g., death in family,
accident, illness), (b) Contextual risks (e.g., poor housing
conditions, financial problems), (c) Parental risks (e.g., par-
ental psychopathology, criminal involvement, and substance
use), and (d) Interpersonal risks (e.g., intimate partner vio-
lence, family conflict). For additional details on these measures
and the computation of the risk domain scores see Cecil et al.
(2014). Information on maternal tobacco smoking for all 109
participants was obtained by self-reported questionnaires in
early, mid, and late pregnancy. Maternal smoking was catego-
rized on the basis of all three questionnaires into ‘never
smoked during pregnancy,’ ‘quit as soon as pregnancy was
known,’ and ‘continued smoking during pregnancy’. Birth
complications (e.g., abruption, preterm rupture, cervical
suture) were recorded at the time of birth and available for
all 109 participants. Subcategories were dichotomized to
contrast mothers with complications (coded 1) versus those
without complications (coded 0) and summed across all three
categories to represent a combined birth complication factor.
For more information see Barker and Maughan (2009) and
Rijlaarsdam et al. (2016).
Psychiatric symptoms. Depression scores (for 90 par-
ticipants) from the Moods and Feelings Questionnaire (Angold,
Costello, Pickles, & Winder, 1987) and symptoms of emotional
problems, conduct problems and hyperactivity (for 96 partic-
ipants) – based on the Strength and Difficulty Questionnaire
(Goodman, 1997) – were available at age 16 as well as a
cumulative measure of psychosis-like symptoms (PLIKS, for
102 participants) at age 18, which was derived by summing the
presence (=1) or absence (=0) of suspected or definite symp-
toms across eight domains (auditory or visual hallucinations,
delusions of being spied on/of reference/of control, thoughts
of being broadcast, thought insertion/withdrawal) based on
self-report items.
Statistical analysis
All analyses were performed in R (version 3.0.1, R Development
Core Team 2008) using limma (version 3.18.13) with default
parameters.
Step 1: How do probes across time (birth and age
7) prospectively associate with AH volume ratio in
early adulthood?. To identify temporally predictive
markers, we ran a longitudinal (birth and age 7), methy-
lome-wide, multilevel model (eBayes estimation in limma) on
all DNA methylation probes present at both time points
(n = 407,368), controlling for intracranial volume. Correla-
tions between probes across time were estimated using the
duplicateCorrelation function in limma, which fits a mixed
linear model by REML individually for each probe and
returns a consensus correlation, which is a robust average
of the individual correlations between time-repeated probes
blocked by subjects. This was then used as an additional
input when fitting multiple linear models. Results were then
ranked using an empirical Bayes method to reduce the
probe-wise sample variances toward a common value and to
increase the degrees of freedom for the individual variances
(Smyth, 2004).
This procedure enabled us to (a) identify probes that are
associated with AH volume ratio across time (as opposed to one
time point only), (b) model methylation data at both time points
concurrently, accounting for correlation patterns between them,
and (c) increase power to detect effects. The genomic inflation
factor lambda and QQ plots were used to compare the methy-
lome-wide distribution of p-values with the expected null distri-
bution (Figure S1). Probes passing a false discovery rate (FDR)
correction threshold of q < .05 were considered significant.
Step 2: Do probes that prospectively associate with
AH volume ratio over time also associate with
prenatal risk factors?. As a second step, we analyzed
whether prenatal risk exposure (Life events, Contextual risks,
Parental risks, and Interpersonal risks) related to DNA methy-
lation probes that were significantly associated with AH
volume ratio (from step 1). We again used a mixed-model
longitudinal design, which allowed us to also investigate (a)
whether prenatal risk predicted methylation at one or both
time points (i.e., main effect of risk); (b) whether methylation
changed significantly over time (i.e., main effect of time), and
(c) whether risk exposure interacted with time to predict
methylation levels (i.e., risk 9 time). For significant markers,
we also tested for indirect effects between prenatal risk and AH
volume ratio via DNA methylation using the R package lavaan
(version 0.5-20; Rosseel, 2012). Last, we examined potentially
confounding effects of maternal smoking during pregnancy
and birth complications on DNA methylation in significant
probes at birth.
Relevance to brain tissue. To investigate the relevance
of the identified DNA methylation markers (as measured in
blood tissue) to temporal lobe brain tissue, we used data from
two published studies. First, we looked at CpG-specific
© 2017 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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correlation estimates using data from paired blood and tem-
poral lobe biopsy samples from 12 epilepsy patients. Blood and
living brain biopsy samples were obtained during neurosurgi-
cal treatment (i.e., both tissue samples were taken at the same
time). For further information, see Walton et al. (2015).
Second, we used data from matched DNA samples isolated
from premortem whole blood and postmortem entorhinal
cortex brain tissue from 71 individuals (http://epigenetics.
iop.kcl.ac.uk/bloodbrain).
Furthermore, to investigate whether genes annotated to our
top DNAmethylation probes are expressed in hippocampal and
amygdala tissue, we accessed data from the Allen Human
Brain Atlas (http://www.brain-map.org/).
Results
Does AH volume ratio relate to psychiatric
symptoms in early adulthood?
Amygdala:hippocampal volume ratio was not asso-
ciated with measures of depression, emotional prob-
lems, conduct problems, and hyperactivity at age 16,
but a larger AH volume ratio was related to increased
psychosis-like symptoms at age 18 (spearman’s
q = .224, p = .023, n = 102).
Which DNA methylation markers at cord and age 7
stably predict AH volume ratio in early adult-
hood?. Inspection of the QQ plot (Figure S1) indi-
cated that test statistics were not overinflated. The
most significant differentially methylated probe
(DMP), cg02219949, passed both FDR and Bonfer-
roni correction (p = 1.13 9 108; q = .005; n = 109;
Table 1, Figures 1 and 2A).
Higher methylation of this probe was positively
correlated with AH volume ratio across both time
points, after controlling for intracranial volume. This
finding remained significant in analyses examining
each time point separately and was driven by a
decrease in hippocampal volume (section 2.2 in
Supporting information). At birth, cg02219949 DNA
methylation (residualized for chip and cell type)
correlated with AH volume ratio (q = .374, p < .001)
after correction for intracranial volume. This was also
the case for cg02219949 DNA methylation at age 7
(q = .378, p < .001). Despite the association between
AH volume ratio and psychosis-like symptoms,
cg02219949 (at either time point or longitudinally)
was unrelated to these symptoms.
Cg02219949 is located in the first intron of Sp6
transcription factor (SP6), a gene implicated in early
development, cell proliferation, and previously associ-
ated with cognitive decline in Alzheimer Disease
(Nakamura et al., 2014; Scohy et al., 2000; Sherva
et al., 2014). Regional analysis of all 24 probes anno-
tated to SP6 revealed six DMPs with nominal effects,
three of which passed Bonferroni correction for 24
tests (section 2.3 in Supporting information). These
findings further support an association between SP6
methylation and AH volume ratio. Other DMPs of
interest, below multiple comparison corrections, were
located in genes such as KCNAB2 (cg13614083;
p = 5.34 9 106) and CACNA1B (cg02849279; p =
8.08 9 106), coding for a voltage-gated potassium
and calcium channel, respectively. Both channels
regulate neurotransmitter release and neuronal
excitability (Lipscombe, Allen, & Toro, 2013; Schultz,
Litt, Smith, Thayer, & McCormack, 1996), and
Table 1 Top 10 differentially methylated probes associated with amygdala:hippocampus volume ratio at birth and age 7
CpG probe Gene Chr Position Methylation change p-Value FDR (q)
cg02219949 SP6 17 45927392 1.36 1.13 9 108 .005
cg18384063 RECQL5 17 73625493 0.32 2.83 9 106 .435
cg18180107 C4orf37 4 99064573 0.24 3.21 9 106 .435
cg08960815 GIMAP4 7 150264767 0.88 4.59 9 106 .467
cg07934552 – 11 32355483 0.30 6.80 9 106 .548
cg02849279 CACNA1B 9 140771661 0.40 8.08 9 106 .548
cg21242009 – 6 6894182 0.78 1.07 9 105 .625
cg13614083 KCNAB2 1 6085872 0.27 1.62 9 105 .723
cg06291594 SULT1A4 16 29473557 0.30 1.71 9 105 .723
cg25816357 GOLT1B 12 21670234 0.28 1.91 9 105 .723
1
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Figure 1 Manhattan plot of methylome-wide DNA methylation
associations (birth and age 7) with amygdala:hippocampus
volume ratio (age 18–21), controlling for intracranial volume.
Red line indicates methylome-wide threshold at p < 1 9 107
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SULT1A3 (cg06291594; p = 5.10 9 106), involved in
dopaminemetabolismand response to glucocorticoids
(Bian et al., 2007; Sidharthan, Minchin, & Butcher,
2013). Interestingly, another DMP on chromosome 11
(cg07934552; p = 2.95 9 106) was found in the
proximity of binding sites for several transcription
factors, including NR3C1, which is also associated
with glucocorticoid response (Oberlander et al., 2008).
Does the prenatal risk environment predict AH
volume ratio-associated DNA methylation?. We
then investigated whether prenatal risks predicted
AH volume ratio-associated SP6cg02219949 methyla-
tion at birth and at age 7. Similar to the previous
analysis, we used longitudinal mixed modeling with
prenatal risk, time period (cord vs. age 7), and their
interaction as predictors for SP6cg02219949 methyla-
tion. Out of the four prenatal risk domains examined
(including Life events, Contextual risks, Parental
risks, and Interpersonal risks), we found that one
risk domain, Life events, was positively associated
with SP6cg02219949 methylation across time at a
nominal significance level [t(100) = 2.02, p = .046;
n = 102; Figure 2B], but the magnitude of correla-
tions at each time point was small (birth: q = .205,
p = .039; age 7: q = .202, p = .042).
While methylation did increase over time [t(100) =
2.90, p = .005], there was no significant time 9
risk interaction [t(100) = 0.19, p = .849].
As a last step, we tested for a potential indirect
effect of SP6cg02219949 methylation on the association
between Life events and AH volume ratio. While Life
events were not directly linked to AH volume ratio
(p = .297), there was a trend effect for the indirect
path via SP6cg02219949 methylation at birth and age 7
(standardized path coefficient = .069, p = .053;
n = 102; section 2.4 in Supporting information).
Maternal smoking and birth complications might
have effects on offspring methylation. Hence, we also
investigated potentially confounding effects of smok-
ing and birth complications. SP6cg02219949 methyla-
tion at birth was not associated with maternal
smoking during pregnancy [F(105) = 2.00, p = .141,
n = 109] or birth complications [F(105) = 0.55,
p = .652, n = 109]. Furthermore, we found no asso-
ciation between gestational age or birth weight and
AH volume ratio or SP6cg02219949 DNA methylation at
either time point.
Replication in a schizophrenia study sample
In light of a link between AH volume ratio and
psychosis-like symptoms, we aimed to replicate the
current findings in a cross-sectional sample of
patients with schizophrenia (n = 101) versus con-
trols (n = 111) featuring measures of DNA methyla-
tion in blood and subcortical brain volumes (section
2.5 in Supporting information and Gollub et al.,
2013). Because DNA methylation was quantified
using the 27k Illumina array, two of the 24 CpGs
within the SP6 gene were available for analysis.
We observed a larger AH volume ratio in patients
compared to controls (bstand = 0.280, p = .040, con-
trolling for age, sex, and intracranial volume; See
Figure S6), supporting our initial results of an asso-
ciation between AH volume ratio and psychosis-like
symptoms. For one of the two available CpGs –
SP6cg27210136 – we observed a small, but significant
diagnosis-by-CpG interaction effect (bstand = 0.318,
p = .020). Specifically, while SP6cg27210136 DNA
methylation correlated positively with AH volume
ratio in patients, this correlation was negative in
healthy controls (see Figure S6).
Relevance to brain tissue. To investigate how
SP6cg02219949 DNA methylation in blood correlates to
that inbrain tissue,we lookedupSP6cg02219949blood–
brain correlation estimates based on two independent
resources (see Methods). DNA methylation in
SP6cg02219949 was moderately and significantly
(q = .62, p = .035) correlated between both tissue
types using data from paired blood and temporal lobe
biopsy samples. This was confirmed using a second
dataset from matched DNA samples isolated from
premortem whole blood and postmortem entorhinal
cortex brain tissue (q = .88, p < .001).
We then investigated whether SP6 is expressed in
hippocampal and amygdala brain tissue using data
Figure 2 Scatterplots. (A) SP6cg02219949 DNA methylation both at birth and at age 7 stably predicted amygdala:hippocampus volume ratio
at age 18. (B) Prenatal risk life events associated with SP6cg02219949 DNA methylation both at birth and at age 7. Birth: triangles, dotted
regression line; age 7: circles, solid regression line
© 2017 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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from the Allen Human Brain Atlas. SP6 was
expressed throughout the hippocampal formation
and the amygdala with highest expression values in
the CA3 and CA4 region of the hippocampus and the
basolateral and -medial nucleus of the amygdala
(Figure S7).
Discussion
Summary
In this study, we used amethylome-wide approach to
test (a) whether DNA methylation in childhood (birth
and age 7) prospectively associates with total AH
volume ratio in early adulthood, and (b) whether
significant DNA methylation markers are influenced
byprenatal risk factors.WhileAHvolume ratio related
to psychosis-like symptoms in early adulthood, we
found that at birthandage7,methylationof aprobe in
the first intron of the geneSP6 predicted increased AH
volume ratio after FDR correction. This probe was
nominally associated with increased stressful life
events during pregnancy and showed significant
convergence with brain tissue methylation.
DNA methylation and AH volume ratio
SP6 belongs to a family of transcription factors that
bind to DNA motifs often found in promoter, enhanc-
ing, and other control regions of many mammalian
genes (Scohy et al., 2000). SP6 is expressed in the
developing ectoderm, which differentiates later to
form the nervous system as well as tooth enamel and
epidermal tissue (Nakamura et al., 2004). Animal
studies have found that 20% of SP6 deficient mice
die within 2 month of age and those that survive are
smaller than the wildtype and also show basic
abnormalities in limb, skin, and tooth development
(Nakamura et al., 2008, 2014; Talamillo et al.,
2010). Interestingly, a polymorphism in SP6, located
in the same intron and 3,000 base pairs upstream of
the methylation probe identified in this study, was
associated with cognitive decline in an Alzheimer
disease cohort (p = 7.99 9 108; Sherva et al.,
2014). These studies support our finding of a poten-
tially important role of SP6 in early neurodevelop-
ment. In our study, SP6cg02219949 (at either time
point or longitudinally) was unrelated to psychosis-
like symptoms, despite an association of AH volume
ratio with these symptoms. This may indicate sub-
threshold effects due to the population design of our
study and young age of the participants. Also some-
what surprisingly, we found that AH volume ratio did
not – as hypothesized – relate to measures of
depression or mood disturbances, but instead to
psychosis-like symptoms. To our knowledge, no
study so far has investigated the link between AH
volume ratio and psychosis, although amygdala and
hippocampal volume reductions are well-replicated
findings in schizophrenia (van Erp et al., 2015).
Using a cross-sectional replication sample of
patients with schizophrenia and healthy controls,
we were able to further support the link between SP6
DNA methylation, AH volume ratio, and psychosis.
We believe that these results further underline the
advantage of using a brain-based measure
(especially in subclinical populations), which
might lie closer to the underlying biology than
behavioral correlates (Gottesman & Gould, 2003).
Furthermore, the fact that methylation levels were
found to be significantly correlated between blood
and brain tissue across two independent resources
supports the relevance of the identified marker to the
brain.
None of the other findings survived corrections for
multiple comparisons. However, some of the highest
ranking probes were associated with genes that may
be interesting candidates for follow-up studies.
KCNAB2 codes for a voltage-gated potassium chan-
nel regulating neurotransmitter release and neu-
ronal excitability. The protein is highly expressed in
the hippocampus (Proepper, Putz, Russell, Boeckers,
& Liebau, 2014) and deletion of the gene in mice
leads to aberrant excitability of neurons in the
amygdala and impairments in associative fear con-
ditioning (Perkowski & Murphy, 2011), a trait also
observed in depressed patients and to be predictive
of later aggressive behavior in children (Gao, Raine,
Venables, Dawson, & Mednick, 2010; Otto et al.,
2014).
SULT1A3 is also highly expressed in temporal struc-
tures such as the hippocampus (Salman, Kadlubar, &
Falany, 2009). This protein is involved in dopamine
metabolism (Sidharthan et al., 2013) and has been
showntorespondtoglucocorticoids (Bianet al.,2007).
Glucocorticoids play akey role in risk for psychological
syndromessuchasdepression, anxiety, andantisocial
behavior (Haller, 2014) and are also strongly respon-
sive to environmental factors such as stress (McEwen
et al., 2015). For instance, a study by Radtke et al.
(2015) reported that DNAmethylation in the glucocor-
ticoid receptor gene NR3C1 not only associated with
depressive or borderline personality disorder symp-
toms but was also moderated by childhood maltreat-
ment. Our findings that SUJLT1A3 and another
independent probe, located in the proximity of binding
sites for transcription factors including NR3C1,
showed a suggestive association with AH volume ratio
provides preliminary evidence for an involvement of
glucocorticoid signaling in brain-based phenotypes of
psychopathology.
DNA methylation and prenatal environmental risk
DNA methylation in SP6 was nominally associated
with one of the four prenatal risk domains examined
– stressful life events during pregnancy. Although
results have to be considered with caution and
warrant further validation, it is possible that they
may be due to the fact that life events were more
© 2017 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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commonly reported (i.e., higher incidence rates) than
other risk domains. Considering that we used an
epidemiological population sample, rates for items
such as parental psychopathology, partner violence,
or substance use were much lower compared to
stressful prenatal Life risks (such as death in the
family, accidents, or illness). However, it is also
possible that there are indeed distinct effects of
specific risk domains, which then impactDNAmethy-
lation in genes related to early development. A study
by van der Waerden, Galera, Saurel-Cubizolles, Sut-
ter-Dallay, and Melchior (2015) – investigating the
associations between environmental risk factors and
maternal depressive symptom trajectories – reported
that not all prenatal risk factors seem to impact
depression trajectories to the same degree. That is,
some variables were more uniquely associated with a
particular trajectory class than others. Whether
indeed prenatal life events exert distinct effects on
brain-related DNA methylation patterns will need to
be investigated further in future studies.
Limitations
Results should be interpreted in light of the following
limitations. First, the time frame investigated in this
study is large, spanning pregnancy to early adult-
hood. Although we found that DNA methylation in a
probe annotated to SP6 both at birth and at age 7
stably predicted AH volume ratio during early adult-
hood, future studies are needed to research the
precise molecular mechanisms in a time-sensitive
manner. Secondly, the observed effects of methyla-
tion on AH volume ratio were rather small, suggest-
ing that there are likely to be other influencing
factors (such as genetic effects) in AH volume ratio
development. Third, DNA methylation was measured
in blood. Although we could provide some evidence
that DNA methylation in SP6cg02219949 is correlated
between blood and brain tissue and that SP6 is
expressed in brain tissue, the functional relevance
especially with respect to gene expression remains to
be investigated in detail. Fourth, our analyses were
based on a homogenous sample of adolescent,
Caucasian males, and future studies should inves-
tigate how well our findings translate to different
populations, including females.
In summary, our findings suggest that environ-
mental risk exposure could lead to long-lasting
epigenetic alterations in genes important for neu-
rodevelopment that in turn may contribute to a
brain-based biomarker of psychopathology. These
results could help to identify intermediate biomark-
ers and potential targets for intervention.
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Key points
• We employed a prospective, epigenome-wide approach to study epigenetic correlates of a larger amygdala:
hippocampal (AH) volume ratio, which was linked to psychosis-like symptoms.
• The association between DNA methylation and AH volume ratio was replicated in a sample of patients with
schizophrenia and healthy controls.
• The study is highly novel in the use of (a) a longitudinal design where DNA methylation precedes brain
imaging measures, and (b) the examination of prenatal risk factors effects on DNA methylation.
• Our results point to genes related to neurodevelopmental functions, which may highlight the potential use of
epigenetics as biomarkers of brain-based correlates of psychopathology.
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